Solitary cysticercus granuloma

Expert Review of Anti-Infective Therapy

Volumn 10, Issue 5, 2012, Pages 597-612

  Garg, Ravindra Kumar ^a   Malhotra, Hardeep Singh ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

albendazole; cysticercosis; epilepsy; neurocysticercosis; seizures

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTIINFLAMMATORY AGENT; CARBAMAZEPINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; OXCARBAZEPINE; PHENYTOIN; PLACEBO; PRAZIQUANTEL; PREDNISOLONE;

BRAIN CALCIFICATION; BRAIN DAMAGE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG POTENTIATION; EDEMA; ENDEMIC DISEASE; EPILEPSY; EPILEPTOGENESIS; GENE; GENETIC SUSCEPTIBILITY; GLIOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL PROCEDURES; IMMUNOPATHOGENESIS; INDIA; INFECTION; INFLAMMATION; INTRACRANIAL TUBERCULOMA; LIFE CYCLE; NEOPLASM; NEUROCYSTICERCOSIS; NEUROIMAGING; NONHUMAN; PATHOLOGICAL ANATOMY; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT DISEASE; REVIEW; SEIZURE; SERODIAGNOSIS; SOLITARY CYSTICERCUS GRANULOMA; TAENIA SOLIUM; TOLL LIKE RECEPTOR GENE; TREATMENT DURATION; TUMOR VOLUME; VASCULAR DISEASE;

ANIMALS; ANTICONVULSANTS; BRAIN; CYTOKINES; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; GRANULOMA, FOREIGN-BODY; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROCYSTICERCOSIS; NEUROIMAGING; SEIZURES; TAENIA SOLIUM; TOLL-LIKE RECEPTOR 4; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862527973     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/eri.12.35     Document Type: Review

References (123)

1. Tandon PN, Bhargava S. Effect of medical treatment on intracranial tuberculoma - A CT study. Tubercle 66(2), 85-97 (1985).
2. Rajshekhar V. Etiology and management of single small CT lesions in patients with seizures: Understanding a controversy. Acta Neurol. Scand. 84(6), 465-470 (1991).
3. Chandy MJ, Rajshekhar V, Prakash S et al. Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet 1(8634), 390-391 (1989).
4. Chandy MJ, Rajshekhar V, Ghosh S et al. Single small enhancing CT lesions in Indian patients with epilepsy: Clinical, radiological and pathological considerations. J. Neurol. Neurosurg. Psychiatr. 54(8), 702-705 (1991).
5. Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J. Neurosurg. 78(3), 402-407 (1993).
6. Ndimubanzi PC, Carabin H, Budke CM et al. A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy. PLoS Negl. Trop. Dis. 4(11), e870 (2010).
7. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerging Infect. Dis. 13(2), 230-235 (2007).
8. Rajshekhar V, Raghava MV, Prabhakaran V, Oommen A, Muliyil J. Active epilepsy as an index of burden of neurocysticercosis in Vellore district, India. Neurology 67(12), 2135-2139 (2006).
9. García HH, Gonzalez AE, Rodriguez S et al.; Cysticercosis Working Group in Peru. Neurocysticercosis: Unraveling the nature of the single cysticercal granuloma. Neurology 75(7), 654-658 (2010).
10. Murthy JM, Yangala R, Srinivas M. The syndromic classification of the International League Against Epilepsy: A hospital-based study from South India. Epilepsia 39(1), 48-54 (1998).
11. Misra S, Verma R, Lekhra OP, Misra NK. CT observations in partial seizures. Neurol. India 42, 24-27 (1994).
12. Yodnopaklow P, Mahuntussanapong A. Single small enhancing CT lesion in Thai patients with acute symptomatic seizures: A clinico-radiological study. Trop. Med. Int. Health 5(4), 250-255 (2000).
13. Wadia RS, Makhale CN, Kelkar AV, Grant KB. Focal epilepsy in India with special reference to lesions showing ring or disc-like enhancement on contrast computed tomography. J. Neurol. Neurosurg. Psychiatr. 50(10), 1298-1301 (1987).
14. Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J. Child Neurol. 15(4), 207-213 (2000).
15. Rajshekhar V, Chandy MJ. Solitary Cysticercus Granuloma: The "Disappearing" Lesion. Orient Longman, Chennai, India (2000).
16. Serpa JA, Graviss EA, Kass JS, White AC Jr. Neurocysticercosis in Houston, Texas: An update. Medicine (Baltimore) 90(1), 81-86 (2011).
17. Rosenfeld EA, Byrd SE, Shulman ST. Neurocysticercosis among children in Chicago. Clin. Infect. Dis. 23(2), 262-268 (1996).
18. Luessi F, Sollors J, Frauenknecht K et al. Neurocysticercosis with a single brain lesion in Germany: A case report. Cases J. 2, 8692 (2009).
19. Raffaldi I, Scolfaro C, Mignone F, Aguzzi S, Denegri F, Tovo PA. An uncommon cause of seizures in children living in developed countries: Neurocysticercosis - A case report. Ital. J. Pediatr. 37, 9 (2011).
20. Yeaney GA, Kolar BS, Silberstein HJ, Wang HZ. Case 163: Solitary neurocysticercosis. Radiology 257(2), 581-585 (2010).
21. Wadley JP, Shakir RA, Rice Edwards JM. Experience with neurocysticercosis in the UK: Correct diagnosis and neurosurgical management of the small enhancing brain lesion. Br. J. Neurosurg. 14(3), 211-218 (2000).
22. Foo SS, Selvan VS, Clarke MJ, Shen EJ. Unusual cause of seizures in Singapore: Neurocysticercosis. Singapore Med. J. 49(6), e147-e150 (2008).
23. Khan FY, Imam YZ, Kamel H, Shafaee M. Neurocysticercosis in Qatari patients: Case reports. Travel Med. Infect. Dis. 9(6), 298-302 (2011).
24. García HH, Gonzalez AE, Evans CA, Gilman RH; Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 362(9383), 547-556 (2003).
25. Gundra UM, Mishra BB, Wong K, Teale JM. Increased disease severity of parasiteinfected TLR2-/- mice is correlated with decreased central nervous system inflammation and reduced numbers of cells with alternatively activated macrophage phenotypes in a murine model of neurocysticercosis. Infect. Immun. 79(7), 2586-2596 (2011).
26. Verma A, Prasad KN, Gupta RK et al. Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis. J. Infect. Dis. 202(8), 1219-1225 (2010).
27. Taylor JL, Hattle JM, Dreitz SA et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74(11), 6135-6144 (2006).
28. Verma A, Prasad KN, Nyati KK et al. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis. Parasitology 138(11), 1423-1428 (2011).
29. Restrepo BI, Alvarez JI, Castaño JA et al. Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile. Infect. Immun. 69(7), 4554-4560 (2001).
30. Uddin J, Gonzalez AE, Gilman RH et al. Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J. Immunol. 185(7), 4478-4484 (2010).
31. Adalid-Peralta L, Fleury A, García-Ibarra TM et al. Human neurocysticercosis: In vivo expansion of peripheral regulatory t cells and their recruitment in the central nervous system. J. Parasitol. 98(1), 142-148 (2011).
32. Stringer JL, Marks LM, White AC Jr, Robinson P. Epileptogenic activity of granulomas associated with murine cysticercosis. Exp. Neurol. 183(2), 532-536 (2003).
33. Patil S, Robinson P, Actor JK, Baig S, White AC Jr. Proinflammatory cytokines in granulomas associated with murine cysticercosis are not the cause of seizures. J. Parasitol. 92(4), 738-741 (2006).
34. Garza A, Tweardy DJ, Weinstock J, Viswanathan B, Robinson P. Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis. J. Biomed. Biotechnol. 2010, 597086 (2010).
35. Robinson P, White AC, Lewis DE, Thornby J, David E, Weinstock J. Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis. Infect. Immun. 70(8), 4534-4538 (2002).
36. Escobar A. The pathology of neurocysticercosis. In: Cysticercosis of the Central Nervous System. Palacios E, Rodriguez-Carbajal J, Taveras JM (Eds). Charles C Thomas, IL, USA, 27-54 (1983).
37. Rajshekhar V, Chacko G, Haran RP, Chandy MJ, Chandi SM. Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: Focus on presence of the parasite and oedema formation. J. Neurol. Neurosurg. Psychiatr. 59(3), 284-286 (1995).
38. Alvarez JI, Colegial CH, Castaño CA, Trujillo J, Teale JM, Restrepo BI. The human nervous tissue in proximity to granulomatous lesions induced by Taenia solium metacestodes displays an active response. J. Neuroimmunol. 127(1-2), 139-144 (2002).
39. Sikasunge CS, Johansen MV, Phiri IK, Willingham AL 3rd, Leifsson PS. The immune response in Taenia solium neurocysticercosis in pigs is associated with astrogliosis, axonal degeneration and altered blood-brain barrier permeability. Vet. Parasitol. 160(3-4), 242-250 (2009).
40. Ooi WW, Wijemanne S, Thomas CB, Quezado M, Brown CR, Nash TE. Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: Histopathological features. Am. J. Trop. Med. Hyg. 85(3), 460-463 (2011).
41. Gupta RK, Awasthi R, Rathore RK et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology 78(9), 618-625 (2012).
42. Serpa JA, Moran A, Goodman JC, Giordano TP, White AC Jr. Neurocysticercosis in the HIV era: A case report and review of the literature. Am. J. Trop. Med. Hyg. 77(1), 113-117 (2007).
43. Prasad S, MacGregor RR, Tebas P, Rodriguez LB, Bustos JA, White AC Jr. Management of potential neurocysticercosis in patients with HIV infection. Clin. Infect. Dis. 42(4), e30-e34 (2006).
44. Modi M, Mochan A, Modi G. Management of HIV-Associated focal brain lesions in developing countries. QJM 97(7), 413-421 (2004).
45. Sheth TN, Pillon L, Keystone J, Kucharczyk W, Pilon L. Persistent MR contrast enhancement of calcified neurocysticercosis lesions. AJNR. Am. J. Neuroradiol. 19(1), 79-82 (1998).
46. Nash TE, Del Brutto OH, Butman JA et al. Calcific neurocysticercosis and epileptogenesis. Neurology 62(11), 1934-1938 (2004).
47. Nash TE, Garcia HH. Diagnosis and treatment of neurocysticercosis. Nat. Rev. Neurol. 7(10), 584-594 (2011).
48. Lucato LT, Guedes MS, Sato JR, Bacheschi LA, Machado LR, Leite CC. The role of conventional MR imaging sequences in the evaluation of neurocysticercosis: Impact on characterization of the scolex and lesion burden. AJNR. Am. J. Neuroradiol. 28(8), 1501-1504 (2007).
49. Garg RK. Single enhancing computerized tomography-detected lesion in immunocompetent patients. Neurosurg. Focus 12(6), e4 (2002).
50. Rajashekhar V. Solitary cerebral cysticercus granuloma. Epilepsia 44(Suppl. 1), 25-28 (2003).
51. Kimura-Hayama ET, Higuera JA, Corona-Cedillo R et al. Neurocysticercosis: Radiologic-pathologic correlation. Radiographics 30(6), 1705-1719 (2010).
52. Singhi P. Neurocysticercosis. Ther. Adv. Neurol. Disord. 4(2), 67-81 (2011).
53. Abdel Razek AA, Watcharakorn A, Castillo M. Parasitic diseases of the central nervous system. Neuroimaging Clin. N. Am. 21(4), 815-41, viii (2011).
54. De Souza A, Nalini A, Kovoor JM, Yeshraj G, Siddalingaiah HS, Thennarasu K. Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution. J. Neurol. Sci. 288(1-2), 135-141 (2010).
55. Carabin H, Ndimubanzi PC, Budke CM et al. Clinical manifestations associated with neurocysticercosis: A systematic review. PLoS Negl. Trop. Dis. 5(5), e1152 (2011).
56. Singh G, Rajshekhar V, Murthy JM et al. A diagnostic and therapeutic scheme for a solitary cysticercus granuloma. Neurology 75(24), 2236-2245 (2010).
57. Garg RK, Kar AM, Singh MK. Prednisolone-responsive headache in patients with solitary cysticercus granuloma and seizures. Headache 44(4), 365-369 (2004).
58. Rajshekhar V. Severe episodic headache as the sole presenting ictal event in patients with a solitary cysticercus granuloma. Acta Neurol. Scand. 102(1), 44-46 (2000).
59. Lath R, Rajshekhar V. Solitary cysticercus granuloma of the brainstem. Report of four cases. J. Neurosurg. 89(6), 1047-1051 (1998).
60. Deckers N, Dorny P. Immunodiagnosis of Taenia solium taeniosis/ cysticercosis. Trends Parasitol. 26(3), 137-144 (2010).
61. Rosas N, Sotelo J, Nieto D. ELISA in the diagnosis of neurocysticercosis. Arch. Neurol. 43(4), 353-356 (1986).
62. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J. Infect. Dis. 159(1), 50-59 (1989).
63. Garcia HH, Parkhouse RM, Gilman RH et al.; Cysticercosis Working Group in Peru. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans. R. Soc. Trop. Med. Hyg. 94(6), 673-676 (2000).
64. Michelet L, Fleury A, Sciutto E et al. Human neurocysticercosis: Comparison of different diagnostic tests using cerebrospinal fluid. J. Clin. Microbiol. 49(1), 195-200 (2011).
65. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A. Conformation-sensitive immunoassays improve the serodiagnosis of solitary cysticercus granuloma in Indian patients. Trans. R. Soc. Trop. Med. Hyg. 101(6), 570-577 (2007).
66. Prabhakaran V, Rajshekhar V, Murrell KD, Oommen A. Taenia solium metacestode glycoproteins as diagnostic antigens for solitary cysticercus granuloma in Indian patients. Trans. R. Soc. Trop. Med. Hyg. 98(8), 478-484 (2004).
67. Verma A, Prasad KN, Singh AK, Nyati KK, Gupta RK, Paliwal VK. Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis. J. Microbiol. Methods 81(2), 175-178 (2010).
68. Wilson M, Bryan RT, Fried JA et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J. Infect. Dis. 164(5), 1007-1009 (1991).
69. Rodriguez S, Dorny P, Tsang VC et al.; Cysticercosis Working Group in Peru. Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J. Infect. Dis. 199(9), 1345-1352 (2009).
70. Harrington AT, Creutzfeldt CJ, Sengupta DJ, Hoogestraat DR, Zunt JR, Cookson BT. Diagnosis of neurocysticercosis by detection of Taenia solium DNA using a global DNA screening platform. Clin. Infect. Dis. 48(1), 86-90 (2009).
71. Maeda T, Ito A, Sako Y et al. Neurocysticercosis case with tuberculomalike epithelioid granuloma strongly suspected by serology and confirmed by mitochondrial DNA. BMJ Case Reports doi:10.1136/bcr.04.2011.4125 (2011) (Epub ahead of print).
72. Rajshekhar V, Chandy MJ. Validation of diagnostic criteria for solitary cerebral cysticercus granuloma in patients presenting with seizures. Acta Neurol. Scand. 96(2), 76-81 (1997).
73. Garg RK. Diagnostic criteria for neurocysticercosis: Some modifications are needed for Indian patients. Neurol. India 52(2), 171-177 (2004).
74. Del Brutto OH, Rajshekhar V, White AC Jr et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 57(2), 177-183 (2001).
75. Bargalló J, Berenguer J, García-Barrionuevo J et al. The "target sign": Is it a specific sign of CNS tuberculoma? Neuroradiology 38(6), 547-550 (1996).
76. Kumar GG, Mahadevan A, Guruprasad AS et al. Eccentric target sign in cerebral toxoplasmosis: Neuropathological correlate to the imaging feature. J. Magn. Reson. Imaging 31(6), 1469-1472 (2010).
77. Kong A, Koukourou A, Boyd M, Crowe G. Metastatic adenocarcinoma mimicking 'target sign' of cerebral tuberculosis. J. Clin. Neurosci. 13(9), 955-958 (2006).
78. Gupta RK, Prakash M, Mishra AM, Husain M, Prasad KN, Husain N. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas-A report of more than 100 lesions. Eur. J. Radiol. 55(3), 384-392 (2005).
79. Pretell EJ, Martinot C Jr, Garcia HH, Alvarado M, Bustos JA, Martinot C; Cysticercosis Working Group in Peru. Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J. Comput. Assist. Tomogr. 29(1), 112-114 (2005).
80. Sethi PK, Kumar BR, Madan VS, Mohan V. Appearing and disappearing CT scan abnormalities and seizures. J. Neurol. Neurosurg. Psychiatr. 48(9), 866-869 (1985).
81. Garg RK, Singh MK, Misra S. Singleenhancing CT lesions in Indian patients with seizures: A review. Epilepsy Res. 38, 91-104 (2000).
82. Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: A study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann. Neurol. 48(2), 181-187 (2000).
83. Goel D, Mittal M, Bansal KK, Singhal A. Natural history of solitary cerebral cysticercosis cases after albendazole therapy: A longitudinal follow-up study from India. Acta Neurol. Scand. 121(3), 204-208 (2010).
84. Rajshekhar V. Rate of spontaneous resolution of a solitary cysticercus granuloma in patients with seizures. Neurology 57(12), 2315-2317 (2001).
85. Singh MK, Garg RK, Nath G, Verma DN, Misra S. Single small enhancing computed tomographic (CT) lesions in Indian patients with new-onset seizures. A prospective follow-up in 75 patients. Seizure 10(8), 573-578 (2001).
86. Rajshekhar V, Chandy MJ. Enlarging solitary cysticercus granulomas. J. Neurosurg. 80(5), 840-843 (1994).
87. Garcia HH, Pretell EJ, Gilman RH et al.; Cysticercosis Working Group in Peru. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N. Engl. J. Med. 350(3), 249-258 (2004).
88. Nash TE, Singh G, White AC et al. Treatment of neurocysticercosis: Current status and future research needs. Neurology 67(7), 1120-1127 (2006).
89. Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: A meta-Analysis of comparative trials. PLoS Negl. Trop. Dis. 2(3), e194 (2008).
90. Rajshekhar V. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. Neurology 43(6), 1238-1240 (1993).
91. Garg RK. Antiparasitic treatment for solitary cysticercus granuloma: To treat or not to treat? Expert Rev. Anti. Infect. Ther. 6(1), 15-19 (2008).
92. Thussu A, Chattopadhyay A, Sawhney IM, Khandelwal N. Albendazole therapy for single small enhancing CT lesions (SSECTL) in the brain in epilepsy. J. Neurol. Neurosurg. Psychiatr. 79(3), 272-275 (2008).
93. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 44(7), 1344-1346 (1994). evaluating the role of albendazole.
94. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: A randomized, placebo-controlled, double blind trial. Pediatr. Infect. Dis. J. 17(8), 696-700 (1998).
95. Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: Clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans. R. Soc. Trop. Med. Hyg. 97(4), 416-421 (2003).
96. Mahanty S, Paredes A, Marzal M et al. Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts. Antimicrob. Agents Chemother. 55(1), 211-217 (2011).
97. Garcia HH, Lescano AG, Lanchote VL et al.; Cysticercosis Working Group in Peru. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis. Br. J. Clin. Pharmacol. 72(1), 77-84 (2011).
98. Kaur S, Singhi P, Singhi S, Khandelwal N. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: A randomized, placebo-controlled double blind trial. Pediatr. Infect. Dis. J. 28(5), 403-406 (2009).
99. Del Brutto OH, Campos X, Sánchez J, Mosquera A. Single-day praziquantel versus 1-week albendazole for neurocysticercosis. Neurology 52(5), 1079-1081 (1999).
100. Cruz I, Cruz ME, Carrasco F, Horton J. Neurocysticercosis: Optimal dose treatment with albendazole. J. Neurol. Sci. 133(1-2), 152-154 (1995).
101. Göngora-Rivera F, Soto-Hernández JL, González Esquivel D et al. Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis. Neurology 66(3), 436-438 (2006).
102. Singh G, Murthy JM. Solitary cysticercus granuloma-treatment with albendazole: What is the optimal duration? Neurol. India 58(4), 507-508 (2010).
103. Bustos JA, Pretell EJ, Llanos-Zavalaga F, Gilman RH, Del Brutto OH, Garcia HH; Cysticercosis Working Group in Peru. Efficacy of a 3-day course of albendazole treatment in patients with a single neurocysticercosis cyst. Clin. Neurol. Neurosurg. 108(2), 193-194 (2006).
104. Chaurasia RN, Garg RK, Agarwall A et al. Three day albendazole therapy in patients with a solitary cysticercus granuloma: A randomized double blind placebo controlled study. Southeast Asian J. Trop. Med. Public Health 41(3), 517-525 (2010).
105. Kaur P, Dhiman P, Dhawan N, Nijhawan R, Pandit S. Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion. Neurol. India 58(4), 560-564 (2010).
106. Khurana N, Garg RK, Verma R, Malhotra HS, Singh MK, Shukla R. Three-day versus 15-day course of albendazole therapy in solitary cysticercus granuloma: An open label randomized trial. J. Neurol. Sci. 316(1-2), 36-41 (2012).
107. Nash TE, Mahanty S, Garcia HH; Cysticercosis Group in Peru. Corticosteroid use in neurocysticercosis. Expert Rev. Neurother. 11(8), 1175-1183 (2011).
108. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia 44(11), 1397-1401 (2003).
109. Singla M, Prabhakar S, Modi M, Medhi B, Khandelwal N, Lal V. Short-course of prednisolone in solitary cysticercus granuloma: A randomized, double-blind, placebo-controlled trial. Epilepsia 52(10), 1914-1917 (2011).
110. Garg RK, Potluri N, Kar AM et al. Short course of prednisolone in patients with solitary cysticercus granuloma: A double blind placebo controlled study. J. Infect. 53(1), 65-69 (2006).
111. Singhi P, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J. Child Neurol. 19(5), 323-327 (2004).
112. Prakash S, Garg RK, Kar AM et al. Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: A random evaluation. Seizure 15(5), 328-332 (2006).
113. Chopra JS, Sawhney IM, Suresh N, Prabhakar S, Dhand UK, Suri S. Vanishing CT lesions in epilepsy. J. Neurol. Sci. 107(1), 40-49 (1992).
114. Murthy JM, Subba Reddy YV. Prognosis of epilepsy associated with single CT enhancing lesion: A long term follow up study. J. Neurol. Sci. 159(2), 151-155 (1998).
115. Thussu A, Arora A, Prabhakar S, Lal V, Sawhney IM. Acute symptomatic seizures due to single CT lesions: How long to treat with antiepileptic drugs? Neurol. India 50(2), 141-144 (2002).
116. Verma A, Misra S. Outcome of short-term antiepileptic treatment in patients with solitary cerebral cysticercus granuloma. Acta Neurol. Scand. 113(3), 174-177 (2006).
117. Singhi P, Dayal D, Khandelwal N. One week versus four weeks of albendazole therapy for neurocysticercosis in children: A randomized, placebo-controlled double blind trial. Pediatr. Infect. Dis. J. 22(3), 268-272 (2003).
118. Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-Analysis: Cysticidal drugs for neurocysticercosis: Albendazole and praziquantel. Ann. Intern. Med. 145(1), 43-51 (2006).
119. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst. Rev. 1, CD000215 (2010).
120. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: A critical review. Epilepsia 39(10), 1025-1040 (1998).
121. Sharma P, Garg RK, Verma R, Singh MK, Shukla R. Risk of seizure recurrence in patients of new-onset partial seizure having a solitary cysticercus granuloma of brain or normal neuroimaging. J. Neurol. Sci. 301(1-2), 21-26 (2011).
122. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 62(12), 2236-2240 (2004).
123. De Souza A, Nalini A, Kovoor JM, Yeshra G, Siddalingaiah HS, Thennarasu K. Perilesional gliosis around solitarycerebral parenchymal cysticerci and long-term seizure outcome: A prospective study using serial magnetization transfer imaging. Epilepsia 52(10), 1918-1927 (2011).